ProGP387 (Putative cytochrome c biogenesis protein)

Home -> ProGPdb -> Search ProGP -> Display data


ProGP ID ProGP387 (Putative cytochrome c biogenesis protein)
Validation Status Characterized
Organism Information
Organism NameCampylobacter jejuni HB93-13
Domain Bacteria
Classification Phylum : Proteobacteria
Class : Epsilonproteobacteria
Orders : Campylobacterales
Family : Campylobacteraceae
Genus : Campylobacter
Species : jejuni
Subspecies : jejuni
Strain : HB93-13
Taxonomic ID (NCBI) 192222
Genome Information
GenBank NC_002163.1
EMBL AL111168
Organism Additional Information Campylobacter jejuni is a microaerophilic, Gram-negative, human pathogen that is the major cause of bacterial food-borne diarrhoea (gastroenteritis). It is most frequently responsible for a form of post-infection neuromuscular paralysis known as Guillain Barre' syndrome. It also leads to an immunoproliferative small intestine disease that is a rare malignant lymphoma of the intestine. Motility is essential for pathogenicity.
Gene Information
Gene Namecj1013c
NCBI Gene ID 905305
GenBank Gene Sequence NC_002163.1.
Protein Information
Protein NamePutative cytochrome c biogenesis protein
UniProtKB/SwissProt ID Q0P9N9
NCBI RefSeq WP_002852963.1
EMBL-CDSCAL35131.1
UniProtKB Sequence >tr|Q0P9N9|Q0P9N9_CAMJE Putative cytochrome C biogenesis protein OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) GN=Cj1013c PE=4 SV=1 MKNIIKSIGDLRVSVVLFLLFALFCALATFIESAYGTPTAWAMVYDTFWFEYIQLLLGIN LLCGMFRYKMFGLKKLPLMIFHISFLFILVGSAMTRYAGFEGILPIREHTQNSLIESSKT SLRISAIKDGERYSAVNDRYIGNLPFANSFKLKLNLGDDQAVLKYKDLILNAHYTYKENN NSDPLLVLMLSQKGSQGVDVKFEKGEVKNIEGVNFAFMNDNVKAPFVKIDENLTLSSSEN LHFLSMLDGQNLDLKIGEKANAKERRLYEINDISFVVKAASLHAQEALEGSNRPQDESFW LWFKSAWLEVGRTMLISTFGEPQNWKNSLLLHFKDFALSNENKNLELTGSNALKLELSYK NESKEFYIFEYNKPIMIELADQKFFISWALSYEQLPFDIYLRDFVLDRYPGSMSPASYAS EITVKNNNENFDYRIFMNNVLDYDGYRFYQSSYDQDEKGTVLSVNKDPGKIPTYIGYFLL CLGMFMNFLNPHSRFRTLARLINKDTLKHTSVIIFILLLSFGSEKTFAQDLNSTLPVVNT NHAKALATLIVQKSADGRMVPFDTLSREILEKIHQSDSYKGQNSNAVMLSMLVDVDKWQL EPFILMPQNQAVRDAIANILEIPSAKYIAYKDFFDENNRYKLQKYVENANRKNPNARGVF DKEIIKLDERANVVNLVFSGELFKFIPVQNNPNNVWLAPFSAVTTLKGDEGHIVLALIQN YFSAVENAFKDGNWIRADEGLKFIKEYQEKIGYKVMPSKTKVEMEIFSNKAEIFVKLAPV YLIAGFLLLILVFSKMVVPNLKISFIFKVVYVLNVLAFVIHTVGLGLRAYLSGHAPWSNG YESMVYIAWALSLSGIFFSRKSPIALSLTSILSGVVLMVAHLSEMNPQITNLVPVLNSYW LSIHVSVITASYGFLGLCALLGIFTLFLMCFLKKDGKYNLNILRNITEATRINEMAMIFG LCLLTVGNFLGAIWANESWGRYWSWDSKETWALVSILVYAAILHLRMIPKYCNQFVFALW SMFAYWVIIMTYFGVNYFLTGLHSYAAGEAAQIPNYVYWGFALMVVLAFFARRKRNFVGK L
Sequence length 1081 AA
Glycosylation Status
Glycosylation Type N- (Asn) linked
Experimentally Validated Glycosite(s) in Full Length ProteinN180, N232, N532 and N733
Glycosite(s) Annotated Protein Sequence >tr|Q0P9N9|Q0P9N9_CAMJE Putative cytochrome C biogenesis protein OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) GN=Cj1013c PE=4 SV=1 MKNIIKSIGDLRVSVVLFLLFALFCALATFIESAYGTPTAWAMVYDTFWFEYIQLLLGIN LLCGMFRYKMFGLKKLPLMIFHISFLFILVGSAMTRYAGFEGILPIREHTQNSLIESSKT SLRISAIKDGERYSAVNDRYIGNLPFANSFKLKLNLGDDQAVLKYKDLILNAHYTYKENN*(180) NSDPLLVLMLSQKGSQGVDVKFEKGEVKNIEGVNFAFMNDNVKAPFVKIDEN*(232)LTLSSSEN LHFLSMLDGQNLDLKIGEKANAKERRLYEINDISFVVKAASLHAQEALEGSNRPQDESFW LWFKSAWLEVGRTMLISTFGEPQNWKNSLLLHFKDFALSNENKNLELTGSNALKLELSYK NESKEFYIFEYNKPIMIELADQKFFISWALSYEQLPFDIYLRDFVLDRYPGSMSPASYAS EITVKNNNENFDYRIFMNNVLDYDGYRFYQSSYDQDEKGTVLSVNKDPGKIPTYIGYFLL CLGMFMNFLNPHSRFRTLARLINKDTLKHTSVIIFILLLSFGSEKTFAQDLN*(532)STLPVVNT NHAKALATLIVQKSADGRMVPFDTLSREILEKIHQSDSYKGQNSNAVMLSMLVDVDKWQL EPFILMPQNQAVRDAIANILEIPSAKYIAYKDFFDENNRYKLQKYVENANRKNPNARGVF DKEIIKLDERANVVNLVFSGELFKFIPVQNNPNNVWLAPFSAVTTLKGDEGHIVLALIQN YFSAVENAFKDGN*(733)WIRADEGLKFIKEYQEKIGYKVMPSKTKVEMEIFSNKAEIFVKLAPV YLIAGFLLLILVFSKMVVPNLKISFIFKVVYVLNVLAFVIHTVGLGLRAYLSGHAPWSNG YESMVYIAWALSLSGIFFSRKSPIALSLTSILSGVVLMVAHLSEMNPQITNLVPVLNSYW LSIHVSVITASYGFLGLCALLGIFTLFLMCFLKKDGKYNLNILRNITEATRINEMAMIFG LCLLTVGNFLGAIWANESWGRYWSWDSKETWALVSILVYAAILHLRMIPKYCNQFVFALW SMFAYWVIIMTYFGVNYFLTGLHSYAAGEAAQIPNYVYWGFALMVVLAFFARRKRNFVGK L
Sequence Around Glycosites (21 AA) LNAHYTYKENNNSDPLLVLML
VKAPFVKIDENLTLSSSENLH
GSEKTFAQDLNSTLPVVNTNH
SAVENAFKDGNWIRADEGLKF
ProGP Web Logo
Technique(s) used for Glycosylation DetectionZIC-HILIC enrichment
Technique(s) used for Glycosylated Residue(s) Detection Reversed Phase LC-Tandem CID/HCD-MS and CID/ETD-MS
Glycan Information
Glycan Annotation Heptasaccharide GalNAc- α1,4-GalNAc- α1,4-(Glcβ1,3)-GalNAc- α1,4-GalNAc- α1,4-GalNAc- α1,3-Bac-β1 where Bac is bacillosamine (2,4-diacetamido-2,4,6-trideoxyglucopyranose)
BCSDB ID 20059
GlyTouCan G38348FF
Technique(s) used for Glycan Identification Reversed Phase LC-Tandem CID/HCD-MS
Literature
Year of Identification2011
Year of Identification Month Wise2011.2.10
Year of Validation 2011
ReferenceScott, N.E., Parker, B.L., Connolly, A.M., Paulech, J., Edwards, A.V., Crossett, B., Falconer, L., Kolarich, D., Djordjevic, S.P., Højrup, P. and Packer, N.H., 2011. Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Molecular & cellular proteomics, 10(2), pp.S1-S18.
Corresponding Author Stuart J Cordwell
ContactSchool of Molecular and Microbial Biosciences, University of Sydney, Sydney, Australia